FDA Import Refusal SCS-1470208-2/21/1 — Merck Kommanditgesellschaft Auf Aktien
The FDA refused shipment SCS-1470208-2/21/1 from Merck Kommanditgesellschaft Auf Aktien (Germany) on Dec 28, 2023. The refused product falls under Drugs and Biologics — LEVOTHYROXINE SODIUM (THYROID HORMONE). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Dec 28, 2023
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 66JAY01 LEVOTHYROXINE SODIUM (THYROID HORMONE)
- Charges
- 75